PurchasingPolicy.orgPURCHASINGPOLICYBETA
← Back to Influence Map
Entity DossierOrganization

HARMONY BIOSCIENCES

PA · US

pharmaceuticals

Tracked direct giving

$0

Tracked donations to candidate

$0

LDA reported lobbying spend

$1,685,000

Connections

6

Lobbying Activity Detail

Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.

Top Lobbying Issues

HCRHealth Issues
$2.3M
PHAPharmacy
$1.6M
MMMMedicare/Medicaid
$880K
INSInsurance
$170K

Lobbying Firms Retained

HARMONY BIOSCIENCES$2.2M
BROWNSTEIN HYATT FARBER SCHRECK, LLP$490K
THORN RUN PARTNERS$250K
HARPER & BAILEY GOVERNMENTAL SOLUTIONS LLC$240K
LMH STRATEGIC SOLUTIONS$160K
Watkins & Eager, PLLC$105K

Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.

Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome

Click a node to see details

Double-click to expand its connections

Relationships

TypeConnected ToDetailsSource
Employed byWatkins & Eager, PLLCHired WATKINS & EAGER PLLC to lobby on PharmaceuticalsSource
Lobbied forSugar Reform Act (S.832, 118th Congress)LDA filing: lobbied on Sugar Reform Act, period 2nd Quarter (Apr 1 - June 30), reported amount $150,000Source
Employed byTHORN RUN PARTNERSHired THORN RUN PARTNERS to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byBROWNSTEIN HYATT FARBER SCHRECK, LLPHired BROWNSTEIN HYATT FARBER SCHRECK, LLP to lobby (4th Quarter (Oct 1 - Dec 31) 2023)Source
Employed byHARPER & BAILEY GOVERNMENTAL SOLUTIONS LLCHired HARPER & BAILEY GOVERNMENTAL SOLUTIONS LLC to lobby (4th Quarter (Oct 1 - Dec 31) 2024)Source
Employed byLMH STRATEGIC SOLUTIONSHired LMH STRATEGIC SOLUTIONS to lobby (3rd Quarter (July 1 - Sep 30) 2025)Source